SJP-0132

DRUG2 trials

Sponsors

Senju Pharmaceutical Co., Ltd., Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd.

Conditions

Dry EyeDry Eye DiseaseDry Eye Syndrome

Phase 1

Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease

CompletedNCT04139122

Senju Pharmaceutical Co., Ltd.Dry Eye Disease, Dry Eye Syndrome

Start: 2019-10-05End: 2020-03-03Updated: 2023-04-20

Phase 3

Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease

CompletedNCT06717152

Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd.Dry Eye

Start: 2024-12-30End: 2025-09-01Updated: 2025-11-26